With the stories of people affected by attacks on reproductive health care continuing to shape public opinion, Abortion in America is expanding its leadership to support storytellers and spotlight the harms caused by abortion bans. Abortion in America, a growing national effort co-founded in 2024 by the late Cecile Richards, Kaitlyn Joshua, and Lauren Peterson […]

NEW YORK CITY, NY / ACCESS Newswire / November 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Alector, Inc. ("Alector" or "the Company") (NASDAQ:ALEC). Investors who purchased Alector securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/ALEC. Investigation

NEW YORK CITY, NY / ACCESS Newswire / November 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Manhattan Associates, Inc. ("Manhattan Associates" or "the Company") (NASDAQ:MANH). Investors who purchased Manhattan Associates securities prior to October 22, 2024, and continue to hold to the present, are encouraged

NEW YORK CITY, NY / ACCESS Newswire / November 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Innodata Inc. ("Innodata" or "the Company") (NASDAQ:INOD). Investors who purchased Innodata securities prior to May 9, 2019, and continue to hold to the present, are encouraged to obtain additional

(Copenhagen:GMAB),(LSE:0MGB), November 6, 2025 Copenhagen, Denmark; Interim Report for the Nine Months Ended September 30, 2025 Highlights Announcement of Genmab's proposed acquisition of Merus N.V. (Merus) Genmab revenue increased 21% compared to the first nine months of 2024, to $2,662 million FDA granted BTD to Rina-S(R) in advanced endometrial cancer Epcoritamab Phase 3 EPCORE(R) FL-1

NEW YORK CITY, NY / ACCESS Newswire / November 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Coty, Inc. ("Coty" or "the Company") (NYSE:COTY). Investors who purchased Coty securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/COTY. Investigation

NEW YORK CITY, NY / ACCESS Newswire / November 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Nextracker Inc. ("Nextracker" or "the Company") (NASDAQ:NXT). Investors who purchased Nextracker securities prior to February 1, 2024, and continue to hold to the present, are encouraged to obtain additional

NEW YORK CITY, NY / ACCESS Newswire / November 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Protalix BioTherapeutics, Inc. ("Protalix" or "the Company") (NYSE:PLX). Investors who purchased Protalix securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/PLX.

NEW YORK CITY, NY / ACCESS Newswire / November 6, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed on behalf of investors in the securities of Spirit Aviation Holdings, Inc. ("Spirit" or the "Company") (OTCMKTS:FLYYQ).�� The class action, filed in the United States District Court for the Southern District of

NEW YORK CITY, NY / ACCESS Newswire / November 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of uniQure N.V. ("uniQure" or "the Company") (NASDAQ:QURE). Investors who purchased uniQure securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/QURE. Investigation